Futures dip on soft U.S.
data, geopolitical risks
Send a link to a friend
[April 17, 2017]
By Yashaswini Swamynathan
(Reuters) -
U.S.
stock index futures were slightly lower on Monday as geopolitical
concerns and weak economic data weighed on sentiment, while the
first-quarter earnings season gathered pace.
* U.S. retail sales fell for the second straight month in March and
consumer prices dropped for the first time in just over a year, a report
from the Commerce Department showed on Friday. Wall Street was closed
for the Good Friday holiday.
* The soft data added to an already downbeat sentiment in the market
after President Donald Trump's national security adviser said the
country, its allies and China were working on a range of responses to
North Korea's latest failed ballistic missile test.
* Mounting geopolitical tensions in the past week have pushed investors
into buying safe-haven assets. Gold prices hit five month highs on
Monday, while the dollar fell to a five-month low as the safe yen rose.
* Investors are also keeping an eye on quarterly earnings to justify
pricey valuations of stocks. The first quarter is expected to be strong,
with earnings of S&P 500 companies estimated to have risen 10.4 percent.
* Among key companies scheduled to report results on Monday include
Netflix and United Continental, which became a subject of international
outrage for dragging a passenger from its plane.
*
Federal Reserve Vice Chairman Stanley Fischer is scheduled to speak at an event
in New York at 5:00 p.m. ET (2100 GMT) and could offer his thoughts on the path
to interest rate hikes and the central bank's plans for its balance sheet.
[to top of second column] |
A street sign for Wall Street is seen outside the New York Stock
Exchange (NYSE) in Manhattan, New York City, U.S. December 28, 2016.
REUTERS/Andrew Kelly
* Shares of Incyte Corp plunged more than 13 percent to $121.95 premarket, while
Eli Lilly dropped 5.2 percent after the U.S. FDA declined to approve a new
drug for rheumatoid arthritis made by the two companies.
* Shares of AbbVie and Pfizer, which already have rheumatoid arthritis drugs in
the market, rose on the news.
Futures snapshot at 6:56 a.m. ET:
* Dow e-minis were down 15 points, or 0.07 percent, with 12,153 contracts
changing hands.
* S&P 500 e-minis were down 2.25 points, or 0.1 percent, with 61,341 contracts
traded.
* Nasdaq 100 e-minis were down 2.25 points, or 0.04 percent, on volume of 12,721
contracts.
(Reporting by Yashaswini Swamynathan in Bengaluru; Editing by Anil D'Silva)
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|